Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Lorvotuzumab (Anti-NCAM1 / CD56) For research use only.
Not for use in humans.

Lorvotuzumab (Anti-NCAM1 / CD56)

Synonyms:

Lorvotuzumab (Anti-NCAM1 / CD56) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine. MW: 145.5 kD.

Lorvotuzumab (Anti-NCAM1 / CD56)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Lorvotuzumab (Anti-NCAM1 / CD56) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine. MW: 145.5 kD.

Product Details

CAS No.  339306-30-8
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lorvotuzumab (Anti-NCAM1 / CD56) | Lorvotuzumab (Anti-NCAM1 / CD56) supplier | purchase Lorvotuzumab (Anti-NCAM1 / CD56) | Lorvotuzumab (Anti-NCAM1 / CD56) cost | Lorvotuzumab (Anti-NCAM1 / CD56) manufacturer | order Lorvotuzumab (Anti-NCAM1 / CD56) | Lorvotuzumab (Anti-NCAM1 / CD56) distributor